ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 607,15
0,47%
Dow Jones
38 778,10
0,00%
DAX
18 109,99
0,20%
Brent Oil
83,765
-0,16%
Bitcoin
65 092,11
-2,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Perrigo Company Plc Ireland (PRGO)

  7. Perrigo Company Plc Ireland (PRGO) Actualités

PRGO

Perrigo Company Plc Irel... (PRGO)

Perrigo Company Plc Ireland
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:PRGO
DateHeureSourceTitreSymboleSociété
11/06/202419h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PRGOPerrigo Company Plc Ireland
10/06/202422h23Edgar (US Regulatory)Form 8-K - Current reportNYSE:PRGOPerrigo Company Plc Ireland
28/05/202414h03PR Newswire (US)Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce ConferenceNYSE:PRGOPerrigo Company Plc Ireland
07/05/202416h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PRGOPerrigo Company Plc Ireland
07/05/202412h31PR Newswire (US)Perrigo Reports First Quarter 2024 Financial Results From Continuing OperationsNYSE:PRGOPerrigo Company Plc Ireland
07/05/202412h28PR Newswire (US)Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) BusinessNYSE:PRGOPerrigo Company Plc Ireland
01/05/202415h42PR Newswire (US)Perrigo Announces Quarterly DividendNYSE:PRGOPerrigo Company Plc Ireland
25/04/202412h00PR Newswire (US)Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 MillionNYSE:PRGOPerrigo Company Plc Ireland
23/04/202414h09PR Newswire (US)Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024NYSE:PRGOPerrigo Company Plc Ireland
09/04/202418h30PR Newswire (US)Opill and WNBA Team Up for Groundbreaking PartnershipNYSE:PRGOPerrigo Company Plc Ireland
08/03/202403h47Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:PRGOPerrigo Company Plc Ireland
04/03/202414h00PR Newswire (US)Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United StatesNYSE:PRGOPerrigo Company Plc Ireland
29/02/202422h21PR Newswire (US)Perrigo to Attend UBS Global Consumer and Retail ConferenceNYSE:PRGOPerrigo Company Plc Ireland
27/02/202423h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:PRGOPerrigo Company Plc Ireland
27/02/202412h30PR Newswire (US)Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency ProgramNYSE:PRGOPerrigo Company Plc Ireland
26/02/202422h30PR Newswire (US)Perrigo Increases its Quarterly DividendNYSE:PRGOPerrigo Company Plc Ireland
13/02/202414h16PR Newswire (US)Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024NYSE:PRGOPerrigo Company Plc Ireland
11/01/202419h58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PRGOPerrigo Company Plc Ireland
29/11/202314h54PR Newswire (US)Perrigo Announces Early Results of Cash Tender Offer for NotesNYSE:PRGOPerrigo Company Plc Ireland
10/11/202315h16PR Newswire (US)Perrigo Announces Cash Tender Offer for NotesNYSE:PRGOPerrigo Company Plc Ireland
09/11/202315h32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:PRGOPerrigo Company Plc Ireland
07/11/202312h30PR Newswire (US)Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing OperationsNYSE:PRGOPerrigo Company Plc Ireland
31/10/202313h54PR Newswire (US)Perrigo to Attend Upcoming Consumer Investor ConferencesNYSE:PRGOPerrigo Company Plc Ireland
24/10/202315h54PR Newswire (US)Perrigo to Release Third Quarter 2023 Financial Results on November 7, 2023NYSE:PRGOPerrigo Company Plc Ireland
11/09/202322h05PR Newswire (US)Perrigo Announces Leadership UpdateNYSE:PRGOPerrigo Company Plc Ireland
30/08/202323h27Dow Jones NewsFDA Warns Three Baby-Formula Makers Over Violations in ProductionNYSE:PRGOPerrigo Company Plc Ireland
08/08/202312h30PR Newswire (US)Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing OperationsNYSE:PRGOPerrigo Company Plc Ireland
02/08/202316h19PR Newswire (US)PERRIGO ANNOUNCES QUARTERLY DIVIDENDNYSE:PRGOPerrigo Company Plc Ireland
25/07/202315h31PR Newswire (US)Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth ConferenceNYSE:PRGOPerrigo Company Plc Ireland
14/07/202313h51IH Market NewsFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and moreNYSE:PRGOPerrigo Company Plc Ireland
 Showing the most relevant articles for your search:NYSE:PRGO

Dernières Valeurs Consultées

NASDAQ
BLAC
Bellevue Life Sciences A...
NASDAQ
ROCAU
ROC Energy Acquisition
COIN
MEKGBP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés